Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-05-22

FDA Approved: BRIMONIDINE TARTRATE — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved brimonidine tartrate ophthalmic solution through an original application by Sandoz Inc. This approval covers its use for reducing intraocular press…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)